Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
about
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseGenetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansGenetic heterogeneity in Alzheimer disease and implications for treatment strategiesModifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patientsPlasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.Quantitative multimodal multiparametric imaging in Alzheimer's disease.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsPlasma β-amyloid in Alzheimer's disease and vascular disease.The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.State of Play in Alzheimer's Disease Genetics.Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease.Aging and are determinative factors of plasma A42 levels
P2860
Q26771808-BFCB8843-26E0-4AC8-95E3-DBA5E0B3E798Q26801647-FC3A3FAD-B37C-4760-A063-1ABBAE71985AQ26995802-3DC4E827-E9F2-4C84-8EC6-31ABE93AF2CAQ30823831-814AA6E0-74A4-4298-B9D8-D7A4AA7B06A9Q35185694-D55D7A99-0DE3-415B-BEA7-0C1CD56D74A3Q36164757-D7A9627B-6B7A-46FA-884A-1FE0D2C1E691Q36165011-B75E7E03-7C67-45FA-84E5-C32FD093CB15Q36949501-296B0C78-093E-4B39-B018-1F311A635C26Q37451440-A225EFC4-22A2-4B64-A0A5-F18F8A10C0F6Q38680904-9B242150-7B27-406F-8CF3-52A15715C147Q39307376-280A35D7-CD29-4F77-AF52-B85559A184CCQ42026115-C008D8E0-0DB6-4092-844B-CEB90AB8E35FQ47587631-1663DE67-09FA-413E-B74E-DAFB47F50C7AQ49135523-38651F15-1D63-46FE-9BCF-EE52E58B3B7DQ55437462-C231F31D-77DF-4483-BED8-0CCB538038F8Q57822409-AAAB2665-BAEC-4498-81B3-6746C5758F3F
P2860
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
@en
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
@nl
type
label
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
@en
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
@nl
prefLabel
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
@en
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
@nl
P2093
P2860
P50
P1476
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
@en
P2093
Chester A Mathis
Holly Soares
John D West
Leslie M Shaw
Mark Inlow
Robert A Koeppe
Shanker Swaminathan
William J Jagust
P2860
P304
P356
10.1016/J.JALZ.2013.01.007
P407
P50
P577
2013-03-26T00:00:00Z